Summary: Published data on the use of transtelephonic electrocardiographic monitoring for evaluation of episodic symptoms suggestive of cardiac arrhythmia are sparse and conflicting. We have reviewed the use of one such device 'Cardiomemo' on our unit over an 18 month period. The study showed that transtelephonic electrocardiographic monitoring is useful in documentation of infrequent or sporadic episodes directly related to symptoms when 24-hour ambulatory electrocardiograph monitoring is normal.
Introduction
Transtelephonic electrocardiographic (ECG) patient and no adhesive electrodes are needed. In addition the system is relatively inexpensive requiring only a transmission unit (around £800) and a receiving station (around £1500). However, the devices are not without disadvantages as the onset and most often the end of arrhythmia will not be recorded. The patient must also be able to handle the system. Short lasting but symptomatic arrhythmia may be missed and a time delay between the onset of the arrhythmia and the occurrence of symptoms may lead to a false negative diagnosis. 
